authID Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 19 2024 - 4:00PM
authID Inc. (Nasdaq: AUID), a leading
provider of biometric identity verification and authentication
solutions, today announced the grant of non-qualified options to
purchase 25,000 shares of common stock to one new employee (the
“Option”). The Option grant date is September 9, 2024, the exercise
price is $7.99 per share and the Option vests in equal amounts
monthly over a period of three years, subject to continued
employment. The term of the Option is ten years. The Option
was granted as an inducement to this employee entering into
employment in accordance with Nasdaq Listing Rule 5635(c)(4).
About authID authID® (Nasdaq: AUID) ensures
enterprises “Know Who’s Behind the Device™” for every customer or
employee login and transaction through its easy-to-integrate,
patented, biometric identity platform. authID quickly and
accurately verifies a user’s identity and eliminates any assumption
of ‘who’ is behind a device to prevent cybercriminals from
compromising account openings or taking over accounts. Combining
secure digital onboarding, FIDO2 passwordless login, and biometric
authentication and account recovery, with a fast, accurate,
user-friendly experience, authID delivers biometric identity
processing in 700ms. Binding a biometric root of trust for each
user to their account, authID stops fraud at onboarding, detects
and stops deepfakes, eliminates password risks and costs, and
provides the fastest, frictionless, and the more accurate user
identity experience demanded by today’s digital ecosystem. Contact
us to discover how authID can help your organization secure your
workforce or consumer applications against identity fraud,
cyberattacks and account takeover at authid.ai.
authID Investor Relations Contact
Gateway Group, Inc.Cody Slach and Alex
Thompson1-949-574-3860AUID@gateway-grp.com
authID (NASDAQ:AUID)
Historical Stock Chart
From Dec 2024 to Jan 2025
authID (NASDAQ:AUID)
Historical Stock Chart
From Jan 2024 to Jan 2025